Follow-up duration | Comparison | COPD | aHR* | ||
---|---|---|---|---|---|
Event | Rate | Event | Rate | (95% CI) | |
Total | |||||
Year <1 | 262 | 7.02 | 607 | 16.68 | 2.01 (1.72-2.32) |
Year 1–3 | 484 | 6.83 | 842 | 12.55 | 1.66 (1.48-1.87) |
Year 3–5 | 373 | 5.26 | 662 | 9.97 | 1.65 (1.45-1.89) |
After year 5 | 358 | 6.37 | 521 | 9.81 | 1.40 (1.22-1.60) |
Female | |||||
Year <1 | 112 | 5.27 | 318 | 15.44 | 2.44 (1.96-3.04) |
Year 1–3 | 220 | 5.48 | 433 | 11.53 | 1.92 (1.62-2.26) |
Year 3–5 | 193 | 6.26 | 316 | 8.55 | 1.63 (1.35-1.97) |
After year 5 | 149 | 4.73 | 260 | 8.91 | 1.70 (1.38-2.09) |
Male | |||||
Year <1 | 150 | 9.32 | 289 | 18.30 | 1.86 (1.40-2.19) |
Year 1–3 | 264 | 8.61 | 409 | 13.86 | 1.67 (1.36-2.04) |
Year 3–5 | 180 | 4.49 | 346 | 11.76 | 1.45 (1.24-1.71) |
After year 5 | 209 | 8.46 | 261 | 10.90 | 1.17 (0.97-1.42) |